Aggressive Investment in New Products, Technologies and Human Resources
First written in FY2016. 17 of 30 entries say "Advanced", first in FY2017. Latest entry: FY2026.
107 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,695 million.」
R&D expenditure was disclosed at ¥1,695 million, with multiple development themes, including new casino machines, 3 models for the commercial market and self-service systems for prize redemption outlets, progressing to specific completion or testing stages. - FY2026-H1RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the current interim consolidated accounting period was ¥876 million. There were no significant changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
The company continued its research and development activities and disclosed expenditure of ¥876 million for the current interim consolidated accounting period. It states that there were no significant changes in the status of those activities. - FY2025-H1AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the current interim consolidated accounting period was ¥875 million. There were no significant changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
While stating that there were no significant changes in the content of its research and development activities, the company disclosed expenditure of ¥875 million for the current interim consolidated accounting period, up from ¥663 million in the same period of the previous year. - FY2024-Q3AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first nine months of the current consolidated cumulative period was ¥1,109 million.」
R&D expenditure for the first nine months was ¥1,109 million, up from ¥991 million in the same period of the previous year. - FY2024-Q2AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥740 million.」
First-half expenditure on research and development activities was ¥740 million, up from ¥663 million in the same period of the previous year. The company states that there were no significant changes in the status of its research and development activities. - FY2023AdvancedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,396 million.」
R&D expenditure increased from ¥1,341 million in the previous fiscal year to ¥1,396 million. Development investment is progressing in areas including automated equipment for casino back offices, products for the distribution and cash-in-transit markets, solutions compatible with ¥500 coins and new banknotes, and transport systems for gaming halls. - FY2023-Q3AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first nine months of the current consolidated cumulative period was ¥991 million.」
R&D expenditure for the first nine months was ¥991 million, up from ¥948 million in the same period of the previous year. - FY2023-Q2AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥663 million.」
First-half expenditure on research and development activities was ¥663 million, up from ¥590 million in the same period of the previous year. - FY2023-Q1AdvancedAnnual report
「The Group's total research and development expenditure for the first quarter of the current consolidated fiscal year was ¥331 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated fiscal year.」
While stating that there were no significant changes in the content of its research and development activities, the company increased expenditure from ¥298 million in the same period of the previous year to ¥331 million. - FY2022-Q3SoftenedAnnual report
「The company controlled development costs by concentrating investment on high-priority projects. The amount of research and development activity undertaken by the Group as a whole during the first nine months of the current consolidated cumulative period was ¥948 million.」
For research and development, the company continued to concentrate investment on high-priority projects and control development costs, reducing expenditure from ¥1,654 million in the same period of the previous year to ¥948 million. - FY2022-Q2SoftenedAnnual report
「In addition, the company worked to spend promotional expenses efficiently through marketing activities suited to the COVID-19 pandemic and to control development costs by concentrating investment on high-priority development projects. The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥590 million.」
For research and development, the company indicated a policy of concentrating investment on high-priority projects while controlling development costs. Cumulative R&D expenditure was ¥590 million, down from ¥759 million in the same period of the previous year. - FY2022-Q1SoftenedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥298 million. There were no significant changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
While stating that there were no significant changes in the content of its research and development activities, the company reduced expenditure from ¥355 million in the same period of the previous year to ¥298 million. - FY2021-Q2RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥759 million. There were no significant changes in the status of the Group's research and development activities during the first half of the current consolidated cumulative period.」
The company spent ¥759 million on research and development activities and stated that there were no significant changes in the status of those activities. - FY2021-Q1RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥355 million. There were no significant changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The company spent ¥355 million on research and development activities and stated that there were no significant changes in the status of those activities. - FY2020-Q3AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first nine months of the current consolidated cumulative period was ¥1,654 million.」
R&D expenditure for the first nine months was ¥1,654 million, up from ¥1,522 million in the same period of the previous year. - FY2020-Q2AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥1,152 million.」
First-half expenditure on research and development activities was ¥1,152 million, up from ¥1,024 million in the same period of the previous year. Increased investment in new product development is also cited as a factor weighing on profit. - FY2020-Q1AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥525 million.」
First-quarter R&D expenditure was ¥525 million, up from ¥472 million in the same quarter of the previous year. The company states that there were no significant changes in the status of its research and development activities. - FY2019AdvancedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥2,182 million.」
R&D expenditure increased from ¥1,810 million in the previous fiscal year to ¥2,182 million, quantifying the expansion of investment in research and development. - FY2019-Q3AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first nine months of the current consolidated cumulative period was ¥1,522 million. There were no significant changes in the status of the Group's research and development activities during the first nine months of the current consolidated cumulative period.」
R&D expenditure for the first nine months was ¥1,522 million, exceeding the ¥1,134 million recorded in the same period of the previous year. The company states that there were no significant changes in the activities themselves. - FY2019-Q2AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥1,024 million.」
First-half expenditure on research and development activities was ¥1,024 million, up from ¥848 million in the same period of the previous year. The company states that there were no significant changes in the status of its activities. - FY2019-Q1AdvancedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥472 million.」
First-quarter R&D expenditure was ¥472 million, up from ¥383 million in the same quarter of the previous year. - FY2018AdvancedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,810 million.」
R&D expenditure increased from ¥1,624 million in the previous fiscal year to ¥1,810 million, quantifying the expansion of investment in research and development. - FY2018-Q3ReframedAnnual report
「The company will accelerate the contribution to sales from the launch of new products by strengthening the development capabilities of its research and development division under a new structure that emphasizes marketing functions.」
The policy on investment in new products and technologies has been reframed to specify a research and development division under a new structure that emphasizes marketing functions, along with contribution to sales from the launch of new products. - FY2018-Q2RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥848 million. There were no significant changes in the status of the Group's research and development activities during the first half of the current consolidated cumulative period.」
The company spent ¥848 million on research and development activities in the first half and stated that there were no significant changes in the status of those activities. - FY2018-Q1RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥383 million. There were no significant changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The company spent ¥383 million on research and development activities in the first quarter, while stating that there were no significant changes in the status of those activities. - FY2017AdvancedAnnual report
「The Group's total research and development expenditure for the current consolidated fiscal year was ¥1,624 million.」
The company continued to invest in research and development, increasing R&D expenditure from ¥1,526 million in the previous fiscal year to ¥1,624 million. - FY2017-Q3RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first nine months of the current consolidated cumulative period was ¥1,134 million. There were no significant changes in the status of the Group's research and development activities during the first nine months of the current consolidated cumulative period.」
The company disclosed R&D expenditure of ¥1,134 million for the first nine months and stated that there were no significant changes in the status of its research and development activities. - FY2017-Q2RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first half of the current consolidated cumulative period was ¥749 million. There were no significant changes in the status of the Group's research and development activities during the first half of the current consolidated cumulative period.」
The company continued its research and development activities and disclosed first-half expenditure of ¥749 million, while stating that there were no significant changes in the status of those activities. - FY2017-Q1RestatedAnnual report
「The amount of research and development activity undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥369 million.」
The company states that there were no significant changes in its research and development activities, while disclosing first-quarter R&D expenditure of ¥369 million. - FY2016First statedAnnual report
「The company will continue to invest actively in the development and commercialization of new products and technologies and in securing human resources, with the aim of creating new businesses to support its next-generation earnings base.」
The company is linking investment in research and development, commercialization and securing human resources to the creation of its next-generation earnings base.